Artelo Biosciences, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

LEASE (Tables)

LEASE (Tables)

12 Months Ended

Dec. 31, 2024

Schedule of operating lease right-of use assets and lease information

		Year ended
		December 31,
		2024				2023

Lease cost:
Operating lease cost		$	32			$	40

Other information:
Cash paid for operating cash flows from operating leases		$	30			$	40
Right-of-use assets obtained in exchange for new operating lease liability		$	111			$	-

Weighted-average remaining lease term — operating leases (years)			2.58				0.67
Weighted-average discount rate — operating leases			7.50	%			3.00	%

Schedule of operating lease liabilities future minimum lease payments

		Total
Year Ended December 31,
2025		$	42
2026			43
2027			30
2028			-
Thereafter			-
			115
Less: Imputed interest			(11	)
Operating lease liabilities			104

Operating lease liability - current			35
Operating lease liability - non-current		$	69